Boundless Bio, Inc.
Boundless Bio, Inc.（BOLD）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
bold · 股价预测 · 20 位分析师（近3月）· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 20 位华尔街分析师
Hold
20 位分析师
共识
评级分布
12 个月目标价
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $1.43
短期股价预测
Bull算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $1.41 | ↓ 1.53% |
1-day model range: $1.4–$1.42. Peak: $1.42 (-1.53%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $1 | -50.0% |
| 2028 | $1 | -62.5% |
| 2029 | $0 | -67.2% |
| 2030 | $0 | -69.2% |
| 2031 | — | -70.2% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · BOLD · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-08-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-28 | Leerink Partners | Downgrade ↓ | Outperform→Market Perform |
| 2024-12-13 | Guggenheim | Downgrade ↓ | Buy→Neutral |
| 2019-12-08 | Evercore ISI Group | Downgrade ↓ | Outperform→In Line |
| 2019-12-05 | JP Morgan | Downgrade ↓ | Overweight→Neutral |
| 2019-12-04 | SVB Leerink | Downgrade ↓ | Outperform→Perform |
| 2019-12-03 | SVB Leerink | Downgrade ↓ | Outperform→Market Perform |
| 2019-12-03 | Chardan Capital | Downgrade ↓ | Buy→Neutral |
| 2019-12-03 | Raymond James | Downgrade ↓ | Outperform→Perform |
| 2019-12-03 | BMO Capital | Downgrade ↓ | Outperform→Perform |
Wall Street analysts have recently issued updated ratings on Boundless Bio, Inc. (BOLD) stock. Of the recent 43 rating actions, 6 were upgrades and 18 were downgrades. 20 analysts currently cover BOLD.
分析师推荐趋势
BOLD analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
↓ 100.0% YoY
Revenue Next Year
$0M
EPS This Year
$-2.38
EPS Next Year
$-1.28
↓ 46.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast BOLD EPS of $-2.38 for the current fiscal year, based on estimates from 2 analysts. The BOLD revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
BOLD 股价预测由两类独立数据源支撑：来自 20 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。BOLD 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Hold。
BOLD 的短期预测（明日）为 $1.41（-1.53%）。 BOLD 对 2027 年的股价预测均值为 $1。 BOLD 对 2030 年的预测区间为 $0–$0。
Boundless Bio, Inc. 在 NASDAQ 上市，代码 BOLD。BOLD 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 30% 对应 Hold 共识。
常见问题
BOLD 预测 · 8 个问题根据 20 位华尔街分析师，BOLD 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $1.43，隐含约 +0.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.